The most comprehensive diabetes knowledge base online. Understand your diabetes. Know your supplies. Make better decisions.
MDS Diabetes
Diabetes
Encyclopedia
Shop Supplies β†’
Researchβœ“ Reviewed for accuracy

Residual Insulin Production Improves Blood Sugar Control in T1D

Adults with type 1 diabetes who still produce some insulin have better CGM readings and lower HbA1c, with meaningful benefits seen at C-peptide levels β‰₯100 pmol/l.

M
MDS Diabetes Team
Β·4 min read
𝕏f
Key takeaways
  • βœ“People with C-peptide β‰₯100 pmol/l were 5x more likely to keep dangerous low blood sugar time under 4%
  • βœ“Higher C-peptide was linked to 10% more time in the healthy blood sugar range
  • βœ“C-peptide β‰₯100 pmol/l nearly doubled the likelihood of achieving a target HbA1c below 7% (53 mmol/mol)
  • βœ“Less glucose variability means steadier, more predictable blood sugars day to day
  • βœ“A simple blood test could help doctors personalise diabetes treatment plans
Quick specs
JournalDiabetologia
Year2026
PMID41165798

What This Study Found

Researchers in the UK studied 945 adults with type 1 diabetes to see whether having even a small amount of remaining insulin-producing ability β€” measured by a protein called C-peptide β€” was linked to better blood sugar control as shown by continuous glucose monitors (CGMs).

What Is C-Peptide?

When your pancreas makes insulin, it also releases C-peptide in equal amounts. So measuring C-peptide in your blood tells doctors how much insulin your body is still producing on its own. In type 1 diabetes, this natural insulin production usually declines over time, but some people retain small amounts for many years.

Key Findings

People with higher C-peptide levels (β‰₯100 pmol/l) had noticeably better CGM results compared to those with very low or undetectable levels:

  • More time in range: 55% vs 45% for those with the lowest C-peptide
  • Less time dangerously low: 1% vs 2% time below range
  • Less glucose variability: Steadier blood sugars throughout the day
  • Less time dangerously high: 10% vs 20% time above 13.9 mmol/l
  • Better HbA1c: Nearly twice as likely to achieve an HbA1c below 53 mmol/mol (7%)
  • 5x more likely to keep time-below-range under the recommended 4% threshold

Who Was More Likely to Have Residual Insulin Production?

People who retained more C-peptide tended to:

  • Have been diagnosed with diabetes more recently
  • Have been older when they were first diagnosed
  • Be male

Why Does This Matter for You?

This research suggests that even a small amount of natural insulin production can meaningfully improve your blood sugar management. The key threshold appears to be 100 pmol/l β€” above this level, the benefits become clinically significant.

Importantly, the researchers say this supports efforts to protect and preserve remaining beta cells (the cells in your pancreas that make insulin). It also suggests that a simple C-peptide blood test could help doctors personalise your diabetes treatment plan.

What This Means in Practice

If you have type 1 diabetes, ask your doctor about having a C-peptide test. Knowing your level could help explain your blood sugar patterns and guide decisions about your treatment. Scientists are also actively working on ways to slow the loss of beta cell function in type 1 diabetes.

References & Sources

Frequently asked questions

C-peptide is a protein released by your pancreas alongside insulin. Measuring it tells your doctor how much insulin your body still makes naturally. Even small amounts of natural insulin production can meaningfully improve your blood sugar control in type 1 diabetes.
Editorial note
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diabetes management. Last reviewed: July 16, 2026 by the MDS Diabetes editorial team.
What to do next
πŸ“š
Read more Research articles
Explore all guides in this topic
β†’
πŸ›’
Shop related supplies at MDS
FSA/HSA eligible Β· Free shipping $60+
β†’
Topics
type 1 diabetesC-peptideCGMcontinuous glucose monitoringtime in rangeHbA1cbeta cell functionhypoglycaemiaresearch

Related articles

Ask Mila about diabetes